We investigated whether acute treatment with agonists affected the subcellular distribution of K opioid receptor (KOPR) in the dorsal horn of the rat lumbar spinal cord by using immunoelectron microscopy. Rats were injected intrathecally (i.t.) with U50,488H (100 nmole), dynorphin A(1-17) (15 nmole), or vehicle. The doses chosen have been shown to induce antinociception. Rats were perfused transcardially 30 min later, and lumbar spinal cords were removed and processed for electron microscopic analysis. KOPR was stained with KT-2, a specific polyclonal antibody against the rat/mouse KOPR(371-380) peptide, followed by gold-labeled secondary antibody and silver intensification. The silver grains were present in axons, terminals, dendrites, and somata, and the association with plasma membranes was quantified in dendrites, because KOPR immunoreactivity was most frequently observed in these profiles. In vehicle-treated rats, similar to 27% of KOPR immunoreactivity was associated with plasma membranes. U50,488H, i.t., did not cause a significant change in the percentage of KOPR present on plasma membranes, whereas dynorphin A, i.t., significantly decreased cell surface KOPR to similar to 19%. In summary, these data indicate that U50,488H and dynorphin A differentially regulate the subcellular distribution of endogenous KOPR. (C) 2009 Wiley-Liss, Inc.
Effects of Acute Agonist Treatment on Subcellular Distribution of kappa Opioid Receptor in Rat Spinal Cord
Creators
Yulin Wang - Temple University
Wei Xu - Temple University
Peng Huang - Temple University
Charles Chavkin - University of Washington
Elisabeth J. Van Bockstaele - Jefferson Hospital for Neuroscience
Lee-Yuan Liu-Chen - Temple University
Publication Details
Journal of neuroscience research, v 87(7), pp 1695-1702
Publisher
Wiley
Number of pages
8
Grant note
R29DA009082 / NATIONAL INSTITUTE ON DRUG ABUSE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); European Commission
P30 DA013429; DA17302; R01 DA009082; DA09082; R01 DA017302 / NIDA NIH HHS; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)
Resource Type
Journal article
Language
English
Academic Unit
Microbiology and Immunology; Pharmacology and Physiology
Web of Science ID
WOS:000265312100019
Scopus ID
2-s2.0-65849295964
Other Identifier
991021903407004721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: